COLON AND PANCREAS CANCER SPECIFIC ANTIGENS AND ANTIBODIES

This invention relates to NPC-1 antigen on the MUC5AC protein and 16C3 antigen on CEACAM5 and CEACAM6 proteins, and 31.1 epitope on the A33 protein are differentially expressed in cancers including, lung cancer, ovarian cancer, pancreas cancer, breast cancer, and colon cancer, and diagnostic and the...

Full description

Saved in:
Bibliographic Details
Main Authors BRISTOL ANDREW J, STAFFORD LEWIS JOE, DU XIULIAN, LUKA JANOS, WANG XUE-PING, SEMENUK MARK, KANTOR JUDITH
Format Patent
LanguageEnglish
Published 25.07.2013
Subjects
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online AccessGet full text

Cover

More Information
Summary:This invention relates to NPC-1 antigen on the MUC5AC protein and 16C3 antigen on CEACAM5 and CEACAM6 proteins, and 31.1 epitope on the A33 protein are differentially expressed in cancers including, lung cancer, ovarian cancer, pancreas cancer, breast cancer, and colon cancer, and diagnostic and therapeutic usages. Further, NPC-1, 16C3, and/or 31.1 epitope specific antibodies and diagnostic and therapeutic methods of use.
Bibliography:Application Number: US201113806200